Robert J. Towarnicki
Algemeen Directeur bij SIRPant Immunotherapeutics, Inc.
Profiel
Robert J.
Towarnicki currently works at SIRPant Immunotherapeutics, Inc., as President, Chief Executive Officer & Director and Biotechnology Innovation Organization, as Member.
Mr. Towarnicki also formerly worked at Cell Pathways, Inc., as Chief Executive Officer, Nucleonics, Inc., as President & Chief Executive Officer from 2003 to 2009, Merck & Co., Inc., as Principal, Integra LifeSciences Holdings Corp., as Principal, Collagen Corp., as Vice President, Quest Diagnostics Infectious Disease, Inc., as General Manager, and Pfizer Pharmaceuticals, Inc., as Operations Manager.
Mr. Towarnicki received his undergraduate degree and graduate degree from Villanova University.
Actieve functies van Robert J. Towarnicki
| Bedrijven | Functie | Begin |
|---|---|---|
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Corporate Officer/Principal | - |
SIRPant Immunotherapeutics, Inc.
 SIRPant Immunotherapeutics, Inc. BiotechnologyHealth Technology SIRPant Immunotherapeutics, Inc. is a clinical-stage immuno-oncology company based in Hummelstown, PA. The company specializes in developing next-generation macrophage-based immunotherapies for the treatment of hematological malignancies and solid tumors. The cell therapy technology employed by SIRPant is based on the reduction of SIRP? expression combined with activation of the patient's own macrophages. This population of SIRP?low activated macrophages is designed to attack the tumor following injection by activating the patient's immune system to produce broad-spectrum anti-tumor activity that utilizes patient T-cells and antibodies targeting cancer neoantigens. The company was founded by Richard F. Fitzgerald, and the CEO is Robert J. Towarnicki. | Algemeen Directeur | - |
Eerdere bekende functies van Robert J. Towarnicki
| Bedrijven | Functie | Einde |
|---|---|---|
Nucleonics, Inc.
 Nucleonics, Inc. Pharmaceuticals: MajorHealth Technology Nucleonics, Inc. develops RNA interference-based therapeutics. It offers DNA vaccine programs. The company was founded in January 2001 and is headquartered in Horsham, PA. | President | 04-12-2009 |
| MERCK & CO., INC. | Corporate Officer/Principal | - |
Pfizer Pharmaceuticals, Inc.
 Pfizer Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Pfizer Pharmaceuticals, Inc. is an American company that manufactures pharmaceutical products. | Operationeel Directeur | - |
| Collagen Corp. | Corporate Officer/Principal | - |
Quest Diagnostics Infectious Disease, Inc.
 Quest Diagnostics Infectious Disease, Inc. Miscellaneous Commercial ServicesCommercial Services Quest Diagnostics Infectious Disease, Inc. provides diagnostic services. It offers anti infective surveillance and consultative services to the diagnosis, treatment, and management of infectious diseases. The company was founded in 1978 and is headquartered in Cypress, CA. | Corporate Officer/Principal | - |
Opleiding van Robert J. Towarnicki
| Villanova University | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| INTEGRA LIFESCIENCES HOLDINGS CORPORATION | Health Technology |
| MERCK & CO., INC. | Health Technology |
| Bedrijven in privébezit | 7 |
|---|---|
Nucleonics, Inc.
Nucleonics, Inc. Pharmaceuticals: MajorHealth Technology Nucleonics, Inc. develops RNA interference-based therapeutics. It offers DNA vaccine programs. The company was founded in January 2001 and is headquartered in Horsham, PA. | Health Technology |
Cell Pathways, Inc.
 Cell Pathways, Inc. Pharmaceuticals: OtherHealth Technology Cell Pathways, Inc. develops and commercializes drugs for the prevention and treatment of cancer | Health Technology |
Quest Diagnostics Infectious Disease, Inc.
Quest Diagnostics Infectious Disease, Inc. Miscellaneous Commercial ServicesCommercial Services Quest Diagnostics Infectious Disease, Inc. provides diagnostic services. It offers anti infective surveillance and consultative services to the diagnosis, treatment, and management of infectious diseases. The company was founded in 1978 and is headquartered in Cypress, CA. | Commercial Services |
| Collagen Corp. | Health Technology |
Pfizer Pharmaceuticals, Inc.
Pfizer Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Pfizer Pharmaceuticals, Inc. is an American company that manufactures pharmaceutical products. | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
SIRPant Immunotherapeutics, Inc.
SIRPant Immunotherapeutics, Inc. BiotechnologyHealth Technology SIRPant Immunotherapeutics, Inc. is a clinical-stage immuno-oncology company based in Hummelstown, PA. The company specializes in developing next-generation macrophage-based immunotherapies for the treatment of hematological malignancies and solid tumors. The cell therapy technology employed by SIRPant is based on the reduction of SIRP? expression combined with activation of the patient's own macrophages. This population of SIRP?low activated macrophages is designed to attack the tumor following injection by activating the patient's immune system to produce broad-spectrum anti-tumor activity that utilizes patient T-cells and antibodies targeting cancer neoantigens. The company was founded by Richard F. Fitzgerald, and the CEO is Robert J. Towarnicki. | Health Technology |
